Product Program year 2025 Source: CMS Open Payments

Arthrex

Device Foot & Ankle and Trauma - Implants - Soft Tissue - IB Ligament Augmentation - IB 2.0

PDI 00888867318137

Open in the dashboard

General payments

$7,189,318

35 payments

Research payments

$0

0 payments

Through program year 2025, $7,189,318 in general payments and $0 in research payments were reported against Arthrex (IB Ligament Augmentation - IB 2.0).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $7,189,318 35

Breakdown

Who paid General payments · program year 2025
  1. Arthrex, Inc. $7,189,318 35 payments
Top recipients General payments · program year 2025
  1. Neal Elattrache Sports Medicine · Los Angeles, CA $5,296,150 74% · 4 payments
  2. Jorge Acevedo Orthopaedic Surgery · Jacksonville, FL $1,701,177 24% · 11 payments
  3. Peter Mangone Foot and Ankle Surgery · Pittsburgh, PA $191,992 3% · 20 payments

Each share is of general payments naming this product in 2025.

Specialties paid General payments · program year 2025
  1. Sports Medicine Orthopaedic Surgery $5,296,150 74% · 1 practitioner
  2. Orthopaedic Surgery $1,701,177 24% · 1 practitioner
  3. Foot and Ankle Surgery Orthopaedic Surgery $191,992 3% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. California $5,296,150 74% · 1 recipient
  2. Florida $1,701,177 24% · 1 recipient
  3. Pennsylvania $191,992 3% · 1 recipient

Each share is of general payments naming this product in 2025 where a state was reported.

35 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record